Increased expression of Cardiotrophin-1 in cardiomyopathy patients

1Colucci WS, Braunwald E. Heart failure: Cardiac function and dysfunction. In: Colucci WS, Editor. Atlas of Heart Diseases, 4th ed. Philadelphia, PA, USA: Blackwell Science. 1995: 128-142.Colucci WS Braunwald E Heart failure: Cardiac function and dysfunction. In: Colucci WS, Editor. Atlas of Heart Diseases, 4th ed Philadelphia, PA, USA Blackwell Science 1995 128–142Search in Google Scholar

2Maron BJ, Towbi, JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006; 113(14): 1807-1816.Maron BJ Towbi JA Thiene G Antzelevitch C Corrado D Arnett D et al Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 2006 113 14 1807 181610.1161/CIRCULATIONAHA.106.174287Search in Google Scholar

3Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008; 117(4): e25-e146.Rosamond W Flegal K Furie K Go A Greenlund K Haase N et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 2008 117 4 e25 e14610.1161/CIRCULATIONAHA.107.187998Search in Google Scholar

4Hershberger RE, Lindenfeld J, Mestroni, L, Seidman, CE, Taylor MR, Towbin JA; Heart Failure Society of America. Genetic evaluation of cardiomyopathy--A Heart Failure Society of America practice guideline. J Card Fail 2009; 15(2): 83-97.Hershberger RE Lindenfeld J Mestroni L Seidman CE Taylor MR Towbin JA; Heart Failure Society of America Genetic evaluation of cardiomyopathy--A Heart Failure Society of America practice guideline J Card Fail 2009 15 2 83 9710.1016/j.cardfail.2009.01.006Search in Google Scholar

5Weigner M, Morgan JP. The causes of dilated cardiomyopathy. UpToDate. 2007; 15(3): 1-10.Weigner M Morgan JP The causes of dilated cardiomyopathy UpToDate 2007 15 3 1 10Search in Google Scholar

6Grenier MA, Osganian SK, Cox GF, Towbin JA, Colan SD, Lurie PR, et al. Design and implementation of the North American pediatric cardiomyopathy registry. Am Heart J. 2000; 139(2 Pt 3): s86-s95.Grenier MA Osganian SK Cox GF Towbin JA Colan SD Lurie PR et al Design and implementation of the North American pediatric cardiomyopathy registry Am Heart J 2000 139 2 Pt 3 s86 s9510.1067/mhj.2000.103933Search in Google Scholar

7Watanabe T, Konii H, Sato K. Emerging roles of cardiotrophin-1 in the pathogenesis and biomarker of atherosclerosis. J. 2018; 1(1): 94-105.Watanabe T Konii H Sato K Emerging roles of cardiotrophin-1 in the pathogenesis and biomarker of atherosclerosis J 2018 1 1 94 10510.3390/j1010010Search in Google Scholar

8Abdul-Ghani M, Suen C, Jiang B, Deng Y, Wedrick JJ, Putinski C, et al. Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart. Cell Res. 2017; 27(10): 1195-1215.Abdul-Ghani M Suen C Jiang B Deng Y Wedrick JJ Putinski C et al Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart Cell Res 2017 27 10 1195 121510.1038/cr.2017.87Search in Google Scholar

9Konii H, Sato K, Kikuchi S, Okiyama H, Watanabe R, Hasegawa A, et al. Stimulatory effects of cardiotrophin 1 on atheroscheloris. Hypertension. 2013; 62(5): 942-950.Konii H Sato K Kikuchi S Okiyama H Watanabe R Hasegawa A et al Stimulatory effects of cardiotrophin 1 on atheroscheloris Hypertension 2013 62 5 942 95010.1161/HYPERTENSIONAHA.113.01653Search in Google Scholar

10Chomczynski P, Mackey K. Short technical reports. Modificatin of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques. 1995; 19(6): 942-945.Chomczynski P Mackey K Short technical reports Modificatin of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 1995 19 6 942 945Search in Google Scholar

11Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, et al. A molecular basis for familial hypertrophic cardiomyopathy: A cardiac myosin heavy chain gene missense mutation. Cell. 1999; 62(5): 999-1006.Geisterfer-Lowrance AA Kass S Tanigawa G Vosberg HP McKenna W Seidman CE et al A molecular basis for familial hypertrophic cardiomyopathy: A cardiac myosin heavy chain gene missense mutation Cell 1999 62 5 999 100610.1016/0092-8674(90)90274-ISearch in Google Scholar

12Thomas DE, Wheeler R, Yousef ZR, Masami ND. The role of echocardiography in guiding management in dilated cardiomyopathy. Eur J Echocardiogr. 2009; 10(8): 15-21.Thomas DE Wheeler R Yousef ZR Masami ND The role of echocardiography in guiding management in dilated cardiomyopathy Eur J Echocardiogr 2009 10 8 15 2110.1093/ejechocard/jep15819889654Search in Google Scholar

13Miura K, Nakagawa H, Morikawa Y, Sasayama S, Matsumori A, Hasegawa K, et al. Epidemiology of idiopathic cardiomyopathy in Japan: Results from a nationwide survey. Heart. 2002; 87(2): 126-130.Miura K Nakagawa H Morikawa Y Sasayama S Matsumori A Hasegawa K et al Epidemiology of idiopathic cardiomyopathy in Japan: Results from a nationwide survey Heart 2002 87 2 126 13010.1136/heart.87.2.126176699411796547Search in Google Scholar

14Jougasaki M, Tachibana I, Luchner A, Leskinen H, Redfield MM, Burnett JC Jr. Augmented cardiac cardio-trophin-1 in experimental congestive heart failure. Circulation. 2000; 101(1): 14-17.Jougasaki M Tachibana I Luchner A Leskinen H Redfield MM Burnett JC Jr Augmented cardiac cardio-trophin-1 in experimental congestive heart failure Circulation 2000 101 1 14 1710.1161/01.CIR.101.1.14Search in Google Scholar

15Freed DH, Cunnington RH, Dangerfield AL, Sutton JS, Dixon IMC. Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart. Cardiovasc Res. 2005; 65(4): 782-792.Freed DH Cunnington RH Dangerfield AL Sutton JS Dixon IMC Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart Cardiovasc Res 2005 65 4 782 79210.1016/j.cardiores.2004.11.026Search in Google Scholar

16Natal C, Antonia Fortuño M, Restituto P, Bazán A, Colina I, Díez J, et al. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am J Physiol Endocrinol Metab. 2008; 294(1): 52-60.Natal C Antonia Fortuño M Restituto P Bazán A Colina I Díez J et al Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome Am J Physiol Endocrinol Metab 2008 294 1 52 6010.1152/ajpendo.00506.2007Search in Google Scholar

17Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, et al. Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001; 38(5): 1485-90.Tsutamoto T Wada A Maeda K Mabuchi N Hayashi M Tsutsui T et al Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy J Am Coll Cardiol 2001 38 5 1485 9010.1016/S0735-1097(01)01576-5Search in Google Scholar